MedTech News

Newly discovered cells in connective tissue open up strategy against pancreatic cancer
Researchers at Umeå University, Sweden, have discovered a previously unknown type of connective tissue cells that surround cancer cells in pancreatic tumors. The newly discovered cells counteract tumor development and may therefore be a target for research into new treatments for pancreatic cancer, which is one of the deadliest forms of cancer. The work is published in the journal Cancer Research.

Supercharged ordinary clinical device gets a better look at the back of the eye
Scientists at the National Institutes of Health (NIH) have leveraged artificial intelligence to transform a device designed to see tissues in the back of the eye into one sharp enough to make out individual cells. The technique provides imaging resolution that rivals the most advanced devices available and is cheaper, faster, and doesn’t require specialized equipment or expertise. The strategy has implications for early detection of disease and for the monitoring of treatment response by making what was once invisible now visible.

A smart bandage clears a new hurdle by monitoring chronic wounds in human patients
Caltech professor of medical engineering Wei Gao and his colleagues are envisioning a smart bandage of the future—a “lab on skin” that could not only help patients and caregivers monitor the status of chronic wounds but also deliver treatment and speed up the healing process for those cuts, incisions, scrapes, and burns that are slow to heal on their own.

3D bioprinting uses collagen to bring vascularized tissue one step closer
This advancement expands the capabilities of how researchers can study disease and build tissues for therapy, such as type 1 diabetes.

Wearable device tracks individual cells in the bloodstream in real time
The technology, which achieves single-cell resolution, could help in continuous, noninvasive patient assessment to guide medical treatments.

Epiminder wins FDA de novo nod for implantable continuous EEG monitor
Epiminder announced today that it received FDA de novo authorization for its implantable continuous electroencephalogram monitoring (iCEM) system.

NeuroOne completes FDA submission for nerve ablation tech to treat facial pain
NeuroOne (Nasdaq:NMTC) announced today that it filed an FDA 510(k) submission for its trigeminal nerve ablation technology.

New Forensic Tool Detects 7 Drugs in Under 5 Minutes
SAN DIEGO, April 23, 2025 /PRNewswire/ — Biolabs International LLC proudly introduces PowderTracer™, a groundbreaking, rapid surface test, and its companion app, designed to swiftly detect seven dangerous drugs. This innovative tool is poised to revolutionize forensic drug detection in the field, providing accurate results in under five minutes. PowderTracer™ addresses the urgent need for rapid, reliable drug identification, particularly in the face of the escalating opioid crisis and the increasingly sophisticated methods used by drug traffickers.